Literature DB >> 9192772

Bcl-2 does not protect Burkitt's lymphoma cells from oxidant-induced cell death.

Y Lee1, E Shacter.   

Abstract

Bcl-2 is an oncogene that confers deregulated growth potential to B lymphocytes through its ability to inhibit apoptotic cell death. A specific molecular activity for the Bcl-2 protein has not been identified, but several lines of evidence have supported a role in protection of cells from oxidative stress. We investigated whether there is a correlation between expression of high levels of Bcl-2 and susceptibility of human Burkitt's lymphoma cell lines to H2O2-induced killing. The amount of H2O2 required to kill 50% of cells in 24 hours varied widely in the seven different lymphoma cell lines that were tested, ranging from 35 to 500 micromol/L H2O2. However, expression of high levels of endogenous Bcl-2 did not protect the cells from H2O2-induced killing, even though it was effective in protecting the cells from apoptosis induced by agents such as A23187. Thus, Bcl-2 was functional in preventing apoptosis but did not act in an antioxidant capacity. The results were confirmed using a Burkitt's lymphoma cell line overexpressing transfected bcl-2. The results may be explained by the observation that H2O2 was inefficient at inducing apoptosis in these mature B-cell lines. Nonapoptotic death induced by H2O2 was not prevented by Bcl-2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192772

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; J Manuel Perez
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

2.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

3.  Gene expression profiling of diabetic and galactosaemic cataractous rat lens by microarray analysis.

Authors:  E Kubo; D P Singh; Y Akagi
Journal:  Diabetologia       Date:  2005-03-11       Impact factor: 10.122

4.  Phospholipase C-gamma1 is required for cell survival in oxidative stress by protein kinase C.

Authors:  Xiao-Chun Bai; Fan Deng; An-Ling Liu; Zhi-Peng Zou; Yu Wang; Zhi-Yong Ke; Qun-Sheng Ji; Shen-Qiu Luo
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

5.  Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cells.

Authors:  Yossef S Levy; Doron Merims; Hanna Panet; Yael Barhum; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

6.  Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis.

Authors:  Yang-ja Lee; Seon-Yong Jeong; Mariusz Karbowski; Carolyn L Smith; Richard J Youle
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

7.  Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells.

Authors:  Baolin Zhang; Yaqin Zhang; Emily Shacter
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

8.  Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75.

Authors:  Baolin Zhang; Yaqin Zhang; Emily Shacter
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.

Authors:  Young-Bin Lim; Tae Jun Park; In Kyoung Lim
Journal:  J Biol Chem       Date:  2008-10-07       Impact factor: 5.157

10.  Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma.

Authors:  Elizabeth J Meredith; Michelle J Holder; Anders Rosén; Adrian Drake Lee; Martin J S Dyer; Nicholas M Barnes; John Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.